VectivBio Holding AG (VECT)
CH1109007893 - Common Stock
Ironwood and VectivBio Announce the Completion of the Tender Offer for VectivBio Shares
VectivBio Extraordinary General Meeting of Shareholders Approved All Proposals
VectivBio Extraordinary General Meeting of Shareholders Approved All Proposals
BASEL, Switzerland, June 26, 2023 (GLOBE NEWSWIRE) -- VectivBio Holding AG (“VectivBio”) (Nasdaq: VECT), a global clinical-stage biopharmaceutical...
IMPORTANT ALERT: Halper Sadeh LLC Investigates VECT, SYNH, LSI, CHRA
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
Ironwood and VectivBio Announce Expiration of Hart-Scott-Rodino Waiting Period for Proposed Acquisition of VectivBio
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ARNC, HMPT, VECT
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
Down 7% in 2023, This Struggling Growth Stock Could Soon Make a Turnaround
Ironwood's plan to purchase a smaller biotech should address some issues that have shareholders concerned.
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VECT, NATI, CTIC, USX
/PRNewswire/ --Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
The Biotech Buying Bonanza: Why The FTC's Amgen Battle Won't Chill The Spree
Big Pharma is facing a patent cliff that could siphon off billions in revenue.
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VECT, RTL, APGN
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
Moore Kuehn Encourages VECT, EMBK, BACK, and RADI Investors to Contact Law Firm
/PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential...
Why Ironwood Pharmaceuticals Stock Bumped Higher Today
Investors indicated approval of the company's upcoming $1 billion asset purchase.
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates GHL, PDCE, VECT
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
Why Shares of VectivBio Holding Are Up Today
A buyout offer by Ironwood Pharmaceuticals lifted the clinical-stage biotech's stock.
VectivBio Stock Catapults 38% After Ironwood Agrees To Buy It For $1 Billion
Both companies are working on treatments for gastrointestinal diseases.
VECT Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of VectivBio Holding AG Is Fair to Shareholders
Ironwood stock falls on deal to buy VectivBio for $1B (NASDAQ:IRWD)
Ironwood Pharmaceuticals (IRWD) fell ~15% in the pre-market Monday after the company agreed to acquire the Swiss biotech VectivBio for nearly $1B. Read more here.
VectivBio Publishes Invitation to the Annual General Meeting
VectivBio Publishes Invitation to the Annual General Meeting
BASEL, Switzerland, May 10, 2023 (GLOBE NEWSWIRE) -- VectivBio Holding AG (“VectivBio”) (Nasdaq: VECT), a clinical-stage biopharmaceutical company...
VectivBio Reports Full Year 2022 Financial Results and Provides Business Update
VectivBio Reports Full Year 2022 Financial Results and Provides Business Update
Continued Strong Progress and Momentum Across Multiple Programs with Key Upcoming Data Milestones Beginning Q2 2023 STARS Phase 3 Program of Apraglutide...
VectivBio to Report Full Year 2022 Financial Results and Provide Business Update on Wednesday, April 19, 2023
Management to Host Conference Call Wednesday, April 19, 2023, at 8.00 a.m. ET
VectivBio and Asahi Kasei Pharma Announce the Start of a Phase 1 Study of Apraglutide in Japan
Single-dose study to assess pharmacokinetics, pharmacological activity, safety and tolerability in healthy Japanese men and women
VectivBio files for $350M mixed shelf offering (NASDAQ:VECT)
VectivBio Holdings (VECT) has filed for a $350M mixed shelf offering.
VectivBio initiated at buy at Jefferies on promise for intestinal disease candidate
Jefferies has initiated VectivBio (VECT) with a buy saying that its GLP2 candidate apraglutide "could revolutionize short bowel syndrome-intestinal failure."
VectivBio Announces Results of Extraordinary General Meeting
-Wouter Joustra Elected to the Board of Directors
VectivBio Announces Results of Extraordinary General Meeting
-Wouter Joustra Elected to the Board of Directors...